Molson Coors Lags Peers as Analysts Trim Targets Before Earnings

TAP fell 2.6% over the past week, landing at $40.12, while the median across its closest beverage peers dropped just 1.2%, putting Molson Coors at the soft end of the group heading into its November 5 earnings release.

Among the peer set, STZ slipped 2.4% on the week and BF.B fell a similar 2.4%, so TAP is not alone in the weakness. But MGPI bucked the trend with an 8.8% gain, and PEP managed a modest positive week. TAP's short interest of 12.1% of free float sits well above the crowd: STZ's equivalent is meaningfully lower, and the 12%-plus reading puts Molson Coors among the more heavily shorted names in consumer staples. That position has actually been unwinding: short interest fell roughly 21% over the past month, from around 28.8 million shares near the start of October to 22.4 million now. The largest step-down happened in the second week of October, when shares outstanding fell from the high-twenties millions in one session. Borrow conditions remain relaxed despite the elevated headline number, with availability at 325% of current short interest and cost to borrow near 0.57%, both consistent with a base of structural rather than tactical short positioning.

The analyst community has been moving in one direction only. Every rating action in October has been a target cut, with no upgrades and no fresh initiations. JP Morgan trimmed its target to $41 from $42 on October 26, keeping a Neutral rating. Barclays cut more sharply, from $41 to $36, maintaining its Underweight stance on October 16. Citigroup and TD Cowen each lowered their targets by $2 to $3 in the same fortnight. The consensus mean target sits at $43.61, implying modest upside from the current price, but the direction of estimate revisions is unambiguous. EPS momentum over the past 30 days ranks in the 18th percentile, meaning cuts have been more aggressive than for most companies in the universe. Against that, TAP's valuation remains extreme on a historical basis: EV/EBIT ranks in the 98th percentile and earnings yield in the 87th, reflecting a stock that the market has re-priced for prolonged volume weakness.

The bear case from Street research is specific. North America generates close to 80% of revenue, and core brands Miller Lite and Coors Light face ongoing share pressure. Management still expects at least $130 million of incremental Midwest Premium costs in 2026 versus 2025, and consensus EPS for the year has been trimmed to $4.75. Volume deleverage and limited near-term catalysts are the recurring themes among neutrally to negatively positioned analysts. The bull case is narrower but present: the Fever-Tree partnership recorded its highest revenue quarter since the arrangement began, and Monaco energy is running ahead of management's internal expectations. Shipments are expected to outpace depletions in the second half, and cash returns continue. Options positioning offers little additional signal in either direction: the put/call ratio at 0.79 is actually slightly below its 20-day average of 0.82, meaning no unusual demand for downside protection has built ahead of the release.

Ownership data adds one structural point worth tracking. BlackRock filed a 13G/A in early October disclosing a stake that nearly doubled relative to its prior filing, from 5.5% to 10.6% of shares. Vanguard Portfolio Management simultaneously updated its filing on October 30, lifting its disclosed stake from 5.2% to 7.05%. Both are passive positions, and the standard caveat applies: 13D/G stakes are as-last-disclosed around the 5% threshold, and changes below that level may not be reported. Still, two of the three largest holders adding material weight in the same filing cycle is worth noting alongside the fact that TAP was removed from the S&P 500 and added to the S&P 600 in September, a mechanical rebalance that forced index trackers to sell around $1.2 billion of stock and buy roughly $930 million. That repositioning is now implemented and the associated flow pressure has cleared.

The August earnings print saw the stock rise 3.6% on the day and hold most of that over the following week. The prior release, in late July, produced a 2.8% decline. The November 5 print arrives with the stock down roughly 2.6% on the week, target estimates from multiple houses sitting at or below the current price, and a short base that has been reducing for a month. The level worth watching is whether volume and cost commentary from management shifts the trajectory of estimate revisions, which have been pointing in one direction for six weeks.